Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S has announced a significant share repurchase program totaling up to DKK 20 billion over a 12-month period starting from February 6, 2024. The company aims to buy back B shares for DKK 2.1 billion by the end of April 2024, and as of April 5, they have repurchased 1,716,500 B shares at an average price of DKK 864.38 each. This strategic financial move underscores Novo Nordisk’s commitment to enhancing shareholder value and reflects the company’s strong position in the global healthcare market.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.